PulmoScreen: A Novel Exhaled Breath Condensate Device

Craig Clements; Amie Wilkinson; Kavit Shah; Sterghios Moschos

PulmoScreen: A Novel Exhaled Breath Condensate Device

Craig Clements, Amie Wilkinson, Kavit Shah, Sterghios Moschos

Research output: Contribution to conference › Poster

120 Downloads (Pure)

Abstract

Exhaled breath condensate (EBC) carries abundant information on airway health and disease, as well as systemic disease. Current EBC samplers focus on volatile compounds and protein biomarkers. This approach does not allow for analysis of biomolecules (e.g. DNA, proteins, metabolites). We are developing an optimised EBC biomolecule sampler and analyser using EBC microbiomics (infectious disease) as a validation approach.

Original language	English
Publication status	Published - 22 Nov 2018
Event	Molecular Diagnostics World Summit 2018 - Hilton London Olympia Hotel, London, United Kingdom Duration: 22 Nov 2018 → 23 Nov 2018 http://www.moleculardiagnostics.co.uk/index.php

Conference

Conference	Molecular Diagnostics World Summit 2018
Abbreviated title	MOLRDIAX 2018
Country/Territory	United Kingdom
City	London
Period	22/11/18 → 23/11/18
Internet address	http://www.moleculardiagnostics.co.uk/index.php

Access to Document

Clements et al - Pulmoscreen posterFinal published version, 2.12 MB

Cite this

@conference{7b7ff1fd39ec4ef39175b12810fa25a5,

title = "PulmoScreen: A Novel Exhaled Breath Condensate Device",

abstract = "Exhaled breath condensate (EBC) carries abundant information on airway health and disease, as well as systemic disease. Current EBC samplers focus on volatile compounds and protein biomarkers. This approach does not allow for analysis of biomolecules (e.g. DNA, proteins, metabolites). We are developing an optimised EBC biomolecule sampler and analyser using EBC microbiomics (infectious disease) as a validation approach.",

author = "Craig Clements and Amie Wilkinson and Kavit Shah and Sterghios Moschos",

year = "2018",

month = nov,

day = "22",

language = "English",

note = "Molecular Diagnostics World Summit 2018, MOLRDIAX 2018 ; Conference date: 22-11-2018 Through 23-11-2018",

url = "http://www.moleculardiagnostics.co.uk/index.php",

}

TY - CONF

T1 - PulmoScreen: A Novel Exhaled Breath Condensate Device

AU - Clements, Craig

AU - Wilkinson, Amie

AU - Shah, Kavit

AU - Moschos, Sterghios

PY - 2018/11/22

Y1 - 2018/11/22

N2 - Exhaled breath condensate (EBC) carries abundant information on airway health and disease, as well as systemic disease. Current EBC samplers focus on volatile compounds and protein biomarkers. This approach does not allow for analysis of biomolecules (e.g. DNA, proteins, metabolites). We are developing an optimised EBC biomolecule sampler and analyser using EBC microbiomics (infectious disease) as a validation approach.

AB - Exhaled breath condensate (EBC) carries abundant information on airway health and disease, as well as systemic disease. Current EBC samplers focus on volatile compounds and protein biomarkers. This approach does not allow for analysis of biomolecules (e.g. DNA, proteins, metabolites). We are developing an optimised EBC biomolecule sampler and analyser using EBC microbiomics (infectious disease) as a validation approach.

M3 - Poster

T2 - Molecular Diagnostics World Summit 2018

Y2 - 22 November 2018 through 23 November 2018

ER -

PulmoScreen: A Novel Exhaled Breath Condensate Device

Abstract

Conference

Access to Document

Fingerprint

Cite this